ARALEZ PHARMACEUTICALS INC - COM (ARLZ)

CUSIP: 03852X100

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
32,345,843
Share change
+2,274,629
Total reported value
$106,742,003
Put/Call ratio
46%
Price per share
$3.30
Number of holders
82
Value change
+$6,439,883
Number of buys
46
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 03852X100?
CUSIP 03852X100 identifies ARLZ - ARALEZ PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARALEZ PHARMACEUTICALS INC - COM (ARLZ) as of Q2 2016

As of 30 Jun 2016, ARALEZ PHARMACEUTICALS INC - COM (ARLZ) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,345,843 shares. The largest 10 holders included PAR CAPITAL MANAGEMENT INC, Broadfin Capital, LLC, JW Asset Management, LLC, ARMISTICE CAPITAL, LLC, DEERFIELD MANAGEMENT CO, JANUS CAPITAL MANAGEMENT LLC, Elk Creek Partners, LLC, Tiger Legatus Capital Management, LLC, VANGUARD GROUP INC, and PUTNAM INVESTMENTS LLC. This page lists 82 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.